Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial.
暂无分享,去创建一个
Jeffrey R Curtis | Kenneth G Saag | A. Westfall | J. Allison | N. Weissman | K. Saag | C. Kiefe | J. Curtis | Catarina I Kiefe | A. Freeman | M. Melton | Andrew O Westfall | Jeroan Allison | Allison Freeman | Angela Becker | Mary Elkins Melton | Marilyn MacArthur | Theresa Ockershausen | Emily Stewart | Norm Weissman | A. Becker | E. Stewart | M. MacArthur | Theresa Ockershausen | Allison Freeman
[1] X. Badia,et al. Does an educational leaflet improve self-reported adherence to therapy in osteoporosis? The OPTIMA study , 2005, Osteoporosis International.
[2] A. Westfall,et al. Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. , 2005, Arthritis and rheumatism.
[3] P. Geusens,et al. Prevention of glucocorticoid osteoporosis: a consensus document of the Dutch Society for Rheumatology , 2004, Annals of the rheumatic diseases.
[4] J. Katz,et al. Educational outreach (academic detailing) regarding osteoporosis in primary care , 2005, Pharmacoepidemiology and drug safety.
[5] D. Klepser,et al. An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[6] J. Allison,et al. Implementing Achievable Benchmarks in Preventive Health: A Controlled Trial in Residency Education , 2006, Academic medicine : journal of the Association of American Medical Colleges.
[7] C. Cooper,et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. , 2000, Rheumatology.
[8] J J Allison,et al. Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. , 2001, JAMA.
[9] Jacques P. Brown,et al. Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1998 .
[10] J. Katz,et al. Multifaceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: a randomized controlled trial. , 2004, Arthritis and rheumatism.
[11] G. Peterson,et al. Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis. , 2004, The Journal of rheumatology.
[12] J. Avorn,et al. Explained variation in a model of therapeutic decision making is partitioned across patient, physician, and clinic factors. , 2006, Journal of clinical epidemiology.
[13] Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines. , 1996, Arthritis and rheumatism.
[14] J. Allison,et al. Racial Disparities in Osteoporosis Prevention in a Managed Care Population , 2003, Southern medical journal.
[15] L Abenhaim,et al. Use of oral corticosteroids in the United Kingdom. , 2000, QJM : monthly journal of the Association of Physicians.
[16] C. Cooper,et al. Use of Inhaled Corticosteroids and Risk of Fractures , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[17] J. Manson,et al. Calcium plus vitamin D supplementation and the risk of fractures. , 2006, The New England journal of medicine.
[18] M. Pringle,et al. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross-sectional study , 1997 .
[19] N. Freemantle,et al. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? , 1999, JAMA.
[20] M. Hochberg,et al. Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1996 .
[21] T. Weiss,et al. Interactive voice response telephone calls to enhance bone mineral density testing. , 2006, The American journal of managed care.
[22] J. Avorn,et al. Osteoporosis action: design of the healthy bones project trial. , 2005, Contemporary clinical trials.
[23] Mikel Aickin,et al. Electronic Medical Record Reminder Improves Osteoporosis Management After a Fracture: A Randomized, Controlled Trial , 2006, Journal of the American Geriatrics Society.
[24] J. Allison,et al. Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort. , 2001, The Journal of rheumatology.
[25] J. Avorn,et al. A randomized controlled trial of mailed osteoporosis education to older adults , 2006, Osteoporosis International.
[26] M. Hochberg,et al. Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs. , 2003, Archives of internal medicine.
[27] S. Wallach,et al. Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. , 1999, Arthritis and rheumatism.